These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6326252

  • 1. Serum ionized calcium, nephrogenous and total urinary cyclic AMP and urinary phosphate in normal subjects.
    Thode J, Holmegaard SN, Siggaard-Andersen O.
    Scand J Clin Lab Invest; 1984 Apr; 44(2):111-8. PubMed ID: 6326252
    [Abstract] [Full Text] [Related]

  • 2. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP, Patron P, Fouqueray B, Prigent A, Paillard M.
    Miner Electrolyte Metab; 1988 Apr; 14(4):221-8. PubMed ID: 2850460
    [Abstract] [Full Text] [Related]

  • 3. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog.
    Fox J, Heath H.
    Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension.
    Papagalanis ND, Skopelitis P, Kourti A, Kostogianni G, Karabatsos A, Gennadiou M, Thomas S, Samartzis M, Mountokalakis T.
    Nephron; 1991 Dec; 59(2):226-31. PubMed ID: 1659670
    [Abstract] [Full Text] [Related]

  • 6. [Usefulness of the determination of nephrogenous cyclic AMP in the diagnosis of primary hyperparathyroidism].
    Bill G, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1983 Mar 05; 113(9):327-30. PubMed ID: 6302835
    [Abstract] [Full Text] [Related]

  • 7. Abnormal responsiveness of nephrogenous cyclic AMP excretion following intravenously administered calcium in normocalcaemic squamous cell cancer patients.
    Naafs MA, Hackeng WH, Koorevaar G, Silberbusch J.
    Bone Miner; 1988 Jul 05; 4(3):289-98. PubMed ID: 2847840
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenous cyclic AMP as a parathyroid function test.
    Broadus AE.
    Nephron; 1979 Jul 05; 23(2-3):136-41. PubMed ID: 220548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Suppressibility of parathyroid function in primary hyperparathyroidism as estimated by nephrogenous cyclic AMP (author's transl)].
    Sohn HE, Yumita S, Unakami H, Miura R, Furukawa Y.
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb 20; 58(2):110-21. PubMed ID: 6282661
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significance.
    Abramson EC, Kukreja SC, Lad TE, Shemerdiak WP, York PA.
    Horm Metab Res; 1984 Apr 20; 16(4):204-7. PubMed ID: 6327481
    [Abstract] [Full Text] [Related]

  • 14. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.
    Law WM, Heath H.
    J Clin Invest; 1983 Sep 20; 72(3):1106-13. PubMed ID: 6309905
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Parameters of evaluation and correlation of renal phosphate handling and of parathyroid function in children.
    Stark H, Eisenstein B, Davidovits M.
    Nephron; 1989 Sep 20; 51(4):478-81. PubMed ID: 2544818
    [Abstract] [Full Text] [Related]

  • 17. Alteration of the circadian rhythm of intact parathyroid hormone following a 96-hour fast.
    Fraser WD, Logue FC, Christie JP, Cameron DA, O'Reilly DS, Beastall GH.
    Clin Endocrinol (Oxf); 1994 Apr 20; 40(4):523-8. PubMed ID: 8187320
    [Abstract] [Full Text] [Related]

  • 18. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
    Shaw JW, Oldham SB, Rosoff L, Bethune JE, Fichman MP.
    J Clin Invest; 1977 Jan 20; 59(1):14-21. PubMed ID: 187621
    [Abstract] [Full Text] [Related]

  • 19. Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy.
    Gallacher SJ, Fraser WD, Logue FC, Dryburgh FJ, Cowan RA, Boyle IT, Ralston SH.
    Calcif Tissue Int; 1992 Dec 20; 51(6):419-23. PubMed ID: 1333351
    [Abstract] [Full Text] [Related]

  • 20. Acute oral calcium load decreases parathyroid secretion and suppresses tubular phosphate loss in long-term renal transplant recipients.
    Dumoulin G, Hory B, Nguyen NU, Henriet MT, Bresson C, Regnard J, Saint-Hillier Y.
    Am J Nephrol; 1995 Dec 20; 15(3):238-44. PubMed ID: 7618649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.